Sarcomas and DDR-Inhibition; a Combined Modality Study

Clinical trial NCT05116254 · TERMINATED

Trial details

NCT number: NCT05116254
Sponsor: The Netherlands Cancer Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Soft Tissue Sarcoma Adult

Start date: 2022-07-18
Primary completion: 2025-12-09
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.